PIK3CD and neoplasm: We found that also in the case of SCC, the opposite targeting of p110δ PI3K in macrophages and RhoA in tumour cells abrogated A431 SCC tumour growth (Fig. 5b) and metastasis as it was suggested by the abolishment of the tumour cell blood burden (Fig. 5c).